Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials

Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials

<i>Background and Objectives</i>: Currently, the standard treatment for non-metastatic triple-negative breast cancer (TNBC) consists of a systemic neoadjuvant (or perioperative) anthracycline plus taxane-based chemotherapy, delivered either sequentially or concomitantly. We performed a n...

Full description

Bibliographic Details
Main Authors: Fausto Petrelli, Gianluca Tomasello, Maria Chiara Parati, Antonio Ghidini, Michele Ghidini, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Roberto Reduzzi, Donatella Gambini, Alberto Zaniboni, Giovanni Faustinelli, Ornella Garrone
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Medicina
Subjects:
breast cancer
triple negative
neoadjuvant
chemotherapy
meta-analysis
pathologic complete response
Online Access:https://www.mdpi.com/1648-9144/60/2/341

Internet

https://www.mdpi.com/1648-9144/60/2/341

Similar Items